Low‐Fat Versus Low‐Carbohydrate Diets, Weight Loss, Vascular Health, and Prevention of Coronary Artery Disease
2010; Wiley; Volume: 25; Issue: 5 Linguagem: Inglês
10.1177/0884533610380614
ISSN1941-2452
Autores Tópico(s)Nutritional Studies and Diet
ResumoNutrition in Clinical PracticeVolume 25, Issue 5 p. 528-541 Invited Commentary Low-Fat Versus Low-Carbohydrate Diets, Weight Loss, Vascular Health, and Prevention of Coronary Artery Disease The Evidence, the Reality, the Challenge, and the Hope Richard Kones MD, FRSM, FACN, Corresponding Author Richard Kones MD, FRSM, FACN [email protected] Cardiometabolic Research Institute, Houston, TexasRichard Kones, 8181 Fannin St U314, Houston, TX 77054; e-mail: [email protected].Search for more papers by this author Richard Kones MD, FRSM, FACN, Corresponding Author Richard Kones MD, FRSM, FACN [email protected] Cardiometabolic Research Institute, Houston, TexasRichard Kones, 8181 Fannin St U314, Houston, TX 77054; e-mail: [email protected].Search for more papers by this author First published: 20 October 2010 https://doi.org/10.1177/0884533610380614Citations: 6Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1Mueller C, Masri B, Hogg J, Mastrogiocomo M, Chiu T-L. Carbohydrate versus fat controlled diet effect on weight loss and coronary artery disease risk: a pilot feeding study. Nutr Clin Pract. 2010; 25: 542–547. 10.1177/0884533610379854 PubMedWeb of Science®Google Scholar 2Kassirer J, Angell M. Losing weight—an ill-fated New Year's resolution. N Engl J Med. 1998; 338: 52–54. 10.1056/NEJM199801013380109 CASPubMedWeb of Science®Google Scholar 3Stunkard AJ, McLaren-Hume M. The results of treatment for obesity. Arch Intern Med. 1959; 103: 79–85. 10.1001/archinte.1959.00270010085011 PubMedWeb of Science®Google Scholar 4Mark AL. Dietary therapy for obesity: an emperor with no clothes. Hypertension. 2008; 51: 1426–1434. 10.1161/HYPERTENSIONAHA.106.085944 CASPubMedWeb of Science®Google Scholar 5Barnes PM, Heyman KM, Freeman G, Schiller JS. Early Release of Selected Estimates Based on Data From the 2009 National Health Interview Survey. Hyattsville, MD: National Center for Health Statistics; June 16, 2010. Google Scholar 6Biltekoff C. Consumer response: the paradoxes of food and health. Ann NY Acad Sci. 2010; 1190: 174–178. 10.1111/j.1749-6632.2009.05268.x CASPubMedWeb of Science®Google Scholar 7Kirk SFL, Penney TL, McHugh TLF. Characterizing the obesogenic environment: the state of the evidence with directions for future research. Obesity Rev. 2010; 11: 109–117. 10.1111/j.1467-789X.2009.00611.x CASPubMedWeb of Science®Google Scholar 8Ludwig DS, Nestle M. Can the food industry play a constructive role in the obesity epidemic? JAMA. 2008; 300: 1808–1811. 10.1001/jama.300.15.1808 CASPubMedWeb of Science®Google Scholar 9Ludwig DS, Pollack HA. Obesity and the economy: from crisis to opportunity. JAMA. 2009; 301: 533–535. 10.1001/jama.2009.52 CASPubMedWeb of Science®Google Scholar 10Clifton PM. Dietary treatment for obesity. Nat Rev Gastroenterol Hepatol. 2008; 5: 672–681. PubMedWeb of Science®Google Scholar 11Kumanyika SK, Obarzanek E, Stettler Net al. Population-based prevention of obesity: the need for comprehensive promotion of healthful eating, physical activity, and energy balance: a scientific statement from American Heart Association Council on Epidemiology and Prevention, Interdisciplinary Committee for Prevention (formerly the Expert Panel on Population and Prevention Science). Circulation. 2008; 118: 428–464. 10.1161/CIRCULATIONAHA.108.189702 PubMedWeb of Science®Google Scholar 12Blackburn GL, Wollner S, Heymsfield SB. Lifestyle interventions for the treatment of class III obesity: a primary target for nutrition medicine in the obesity epidemic. Am J Clin Nutr. 2010; 91(suppl): 289S–292S. 10.3945/ajcn.2009.28473D CASPubMedWeb of Science®Google Scholar 13Bray G, Kushner R, Ryan D, Aronne L. The Obesity Epidemic! Exploring Emerging Strategies for Weight Control and Risk Reduction. Presented at the Marriott Wardman Park Hotel, Washington, DC, October 26, 2009. Transcript available at http://cme.medscape.com/viewarticle/712986_transcript . Accessed July 1, 2010. Google Scholar 14Wing RR, Phelan S. Long-term weight loss maintenance. Am J Clin Nutr. 2005 82: 222S–225S. 10.1093/ajcn/82.1.222S CASPubMedWeb of Science®Google Scholar 15Wing RR, Hill JO. Successful weight loss maintenance. Annu Rev Nutr. 2001; 21: 323–341. 10.1146/annurev.nutr.21.1.323 CASPubMedWeb of Science®Google Scholar 16Phelan S, Wyatt H, Nassery Set al. Three-year weight change in successful weight losers who lost weight on a low-carbohydrate diet. Obesity. 2007; 15: 2470–2477. 10.1038/oby.2007.293 CASPubMedWeb of Science®Google Scholar 17Mark DH. Deaths attributable to obesity. JAMA. 2005; 293: 1918–1919. 10.1001/jama.293.15.1918 CASPubMedWeb of Science®Google Scholar 18O'Neil CE, Nicklas TA. Relationship between diet/ physical activity and health. Am J Lifestyle Med. 2007; 1: 457–481. 10.1177/1559827607306433. Google Scholar 19Stevens J, McClain JE, Truesdale PK. Commentary: obesity claims and controversies. Int J Epidemiol. 2006; 35: 77–78. 10.1093/ije/dyi258 PubMedWeb of Science®Google Scholar 20Fantuzzi G, Mazzone T. Adipose tissue and atherosclerosis: exploring the connection. Athero Thromb Vasc Biol. 2007; 27: 996–1003. 10.1161/ATVBAHA.106.131755 CASPubMedWeb of Science®Google Scholar 21Chamberlain J, Francis S, Brookes Zet al. Interleukin-1 regulates multiple atherogenic mechanisms in response to fat feeding. PLoS ONE. 2009; 4: e5073. 10.1371/journal.pone.0005073 CASPubMedWeb of Science®Google Scholar 22Lamon BD, Hajjar DP. Inflammation at the molecular interface of atherogenesis: an anthropological journey. Am J Pathol. 2008; 173: 1253–1264. 10.2353/ajpath.2008.080442 PubMedWeb of Science®Google Scholar 23Libby P, Ridker PM, Hansson GK. Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol. 2009; 54: 2129–2138. 10.1016/j.jacc.2009.09.009 CASPubMedWeb of Science®Google Scholar 24Stefan N, Kantartzis K, Machann Jet al. Identification and characterization of metabolically benign obesity in humans. Arch Intern Med. 2008; 168: 1609–1616. 10.1001/archinte.168.15.1609 PubMedWeb of Science®Google Scholar 25Flegal KM, Graubard BI, Williamson DF, Mitchell H, Gail MH. Excess deaths associated with underweight, overweight, and obesity. JAMA. 2005; 293: 1861–1867. 10.1001/jama.293.15.1861 CASPubMedWeb of Science®Google Scholar 26Ryan D. Risks and benefits of weight loss: challengers to obesity research. Eur Heart J. 2005; 7(suppl L): L27–L31. 10.1093/eurheartj/sui083 Web of Science®Google Scholar 27Karelis AD, Faraj M, Bastard J-Pet al. The metabolically healthy but obese individual presents a favorable inflammation profile. J Clin Endocrinol Metab. 2005; 90: 4145–4150. 10.1210/jc.2005-0482 CASPubMedWeb of Science®Google Scholar 28Ärnlöv J, Ingelsson E, Sundström J, Lind L. Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men. Circulation. 2010; 121: 230–236. 10.1161/CIRCULATIONAHA.109.887521 PubMedWeb of Science®Google Scholar 29Lee I-M, Djoussé L, Sesso HD, Wang L, Buring JE. Physical activity and weight gain prevention. JAMA. 2010; 303: 1173–1179. 10.1001/jama.2010.312 CASPubMedWeb of Science®Google Scholar 30Thompson PD, Buchner D, Piña ILet al. Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity). Arterioscler Thromb Vasc Biol. 2003; 23: e42–e49. 10.1161/01.ATV.0000089628.63625.D4 CASWeb of Science®Google Scholar 31Hamer M, Steptoe A. Prospective study of physical fitness, adiposity, and inflammatory markers in healthy middle-aged men and women. Am J Clin Nutr. 2009; 89: 85–89. 10.3945/ajcn.2008.26779 CASPubMedWeb of Science®Google Scholar 32Larson-Meyer DE, Redman L, Heilbronn LK, Martin CK, Ravussin E. Caloric restriction with or without exercise: the fitness versus fatness debate. Med Sci Sports Exerc. 2010; 42: 152–159. 10.1249/MSS.0b013e3181ad7f17 PubMedWeb of Science®Google Scholar 33Duncan GE. The "fit but fat" concept revisited: population-based estimates using NHANES. Int J Behav Nutr Phys Act. 2010; 7: 47. 10.1186/1479-5868-7-47 PubMedWeb of Science®Google Scholar 34Kones R. After cardiac surgery, how does nutrition fit in with risk factors? JPEN J Parenter Enteral Nutr. 2010; 34: 163–167. 10.1177/0148607109343111 PubMedWeb of Science®Google Scholar 35Van Gaal LF, Mertens IL, Ballaux D. What is the relationship between risk factor reduction and degree of weight loss? Eur Heart J. 2005; 7(suppl L): L21–L26. 10.1093/eurheartj/sui082 Web of Science®Google Scholar 36Blair SN, Kohl HW III, Barlow CEet al. Changes in physical fitness and all-cause mortality: a prospective study of healthy and unhealthy men. JAMA. 1995; 273: 1093–1098. 10.1001/jama.1995.03520380029031 CASPubMedWeb of Science®Google Scholar 37Lloyd-Jones D, Adams RJ, Brown TM et al; on behalf of the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics—2010 update: a report from the American Heart Association. Circulation. 2010; 121: e46–e215. PubMedWeb of Science®Google Scholar 38 Health, United States, 2009: With Special Feature on Medical Technology. Hyattsville, MD: National Center for Health Statistics; 2010. Google Scholar 39Popkin BM. Recent dynamics suggest selected countries catching up to US obesity. Am J Clin Nutr. 2010; 91(suppl): 284S–288S. 10.3945/ajcn.2009.28473C CASPubMedWeb of Science®Google Scholar 40 Institute of Medicine. A population-based policy and systems change approach to prevent and control hypertension 2010. Washington, DC: The National Academies Press. Brief report available at http://www.iom.edu/Reports/2010/A-Population-Based-Policy-and-Systems-Change-Approach-to-Prevent-and-Control-Hypertension/Report-Brief-Prevent-and-Control-Hypertension.aspx . Accessed June 9, 2010. Google Scholar 41Kones R, Phillips JH. Prevention of heart cell death. In: PN Yu JF Goodwin, eds. Progress in Cardiology. Vol 4. Philadelphia, PA: Lea & Febiger; 1975: 199–224. Google Scholar 42Markku L. Cardiovascular disease in type 2 diabetes from population to man to mechanisms: the Kelly West Award Lecture 2008. Diabetes Care. 2010; 33: 442–449. 10.2337/dc09-0749 CASPubMedWeb of Science®Google Scholar 43Capewell S, Ford ES, Croft JB, Critchley JA, Greenlund KJ, Labarthe DR. Cardiovascular risk factor trends and potential for reducing coronary heart disease mortality in the United States of America. Bull World Health Organ. 2010; 88: 120–130. 10.2471/BLT.08.057885 PubMedWeb of Science®Google Scholar 44 Department of Health and Human Services. Healthy people 2010: understanding and improving health and objectives for improving health. Washington, DC: Government Printing Office; 2010. http://www.cdc.gov/nchs/healthy_people.htm . Accessed June 9, 2010. Google Scholar 45Ford ES, Ajani UA, Croft JBet al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med. 2007; 356: 2388–2398. 10.1056/NEJMsa053935 CASPubMedWeb of Science®Google Scholar 46Ford ES, Capewell S. Coronary heart disease mortality among young adults in the U.S. from 1980 through 2002: concealed leveling of mortality rates. J Am Coll Cardiol. 2007; 50: 2128–2132. 10.1016/j.jacc.2007.05.056 PubMedWeb of Science®Google Scholar 47Fryar CD, Hirsch R, Eberhardt MS, Yoon SS, Wright JD. Hypertension, High Serum Total Cholesterol, and Diabetes: Racial and Ethnic Prevalence Differences in U.S. Adults, 1999-2006. Data Brief No. 36. Hyattsville, MD: National Center for Health Statistics; April 2010. Google Scholar 48Lloyd-Jones D, Adams R, Carnethon Met al. Heart disease and stroke statistics—2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2009; 119: e21–e181. 10.1161/CIRCULATIONAHA.108.191261 PubMedWeb of Science®Google Scholar 49Hingorani AD, Psaty BM. Primary prevention of cardiovascular disease: time to get more or less personal? JAMA. 2009; 302: 2144–2145. 10.1001/jama.2009.1698 PubMedWeb of Science®Google Scholar 50Marma AK, Berry JD, Ning H, Persell SD, Lloyd-Jones DM. Distribution of 10-year and lifetime predicted risks for cardiovascular disease in US adults: findings from the National Health and Nutrition Examination Survey 2003 to 2006. Circ Cardiovasc Qual Outcomes. 2010; 3: 8–14. 10.1161/CIRCOUTCOMES.109.869727 PubMedWeb of Science®Google Scholar 51Lloyd-Jones DM, Hong Y, Labarthe D et al; on behalf of the American Heart Association Strategic Planning Task Force and Statistics Committee. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic impact goal through 2020 and beyond. Circulation. 2010; 121: 586–613. 10.1161/CIRCULATIONAHA.109.192703 PubMedWeb of Science®Google Scholar 52Rose G. Incubation period of coronary heart disease. Int J Epidemiol. 2005; 34: 242–244. 10.1093/ije/dyh308 PubMedWeb of Science®Google Scholar 53Rose G. The Strategy of Preventive Medicine. Oxford, UK: Oxford University Press; 1992. Google Scholar 54Cannon CP, Braunwald E, McCabe CHet al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med. 2004; 350: 1495–1504. 10.1056/NEJMoa040583 CASPubMedWeb of Science®Google Scholar 55Libby P. The forgotten majority: unfinished business in cardiovascular risk reduction. J Am Coll Cardiol. 2005; 46: 1225–1228. 10.1016/j.jacc.2005.07.006 PubMedWeb of Science®Google Scholar 56Alla VM, Kaushik M, Mooss A. Targeting residual risk: the rationale for the use of non-HDL cholesterol. South Med J. 2010; 103: 434–437. 10.1097/SMJ.0b013e3181d7e3a8 PubMedWeb of Science®Google Scholar 57Kones R. Recent advances in the management of chronic stable angina, I: approach to the patient, diagnosis, pathophysiology, risk stratification, and gender disparities. Vasc Health Risk Manag. 2010; 6: 653–656. Google Scholar 58Eifert S, Mair H, Boulesteix A-Let al. Mid-term outcomes of patients with PCI prior to CABG in comparison to patients with primary CABG. Vasc Health Risk Manag. 2010; 6: 495–501. 10.2147/VHRM.S8560 PubMedGoogle Scholar 59Hata M, Takayama T, Sezai A, Yoshitake I, Hirayama A, Minami K. Efficacy of aggressive lipid controlling therapy for preventing saphenous vein graft disease. Ann Thorac Surg. 2009; 88: 1440–1444. 10.1016/j.athoracsur.2009.06.009 PubMedWeb of Science®Google Scholar 60Gould KL, Ornish D, Kirkeeide Ret al. Improved stenosis geometry by quantitative coronary arteriography after vigorous risk factor modification. Am J Cardiol.1992; 69: 845–853. 10.1016/0002-9149(92)90781-S CASPubMedWeb of Science®Google Scholar 61Gould KL, Ornish D, Scherwitz Let al. Changes in myocardial perfusion abnormalities by positron emission tomography after long-term, intense risk factor modification. JAMA. 1995; 274: 894–901. CASPubMedWeb of Science®Google Scholar 62Ornish D, Scherwitz LW, Billings JHet al. Intensive lifestyle changes for reversal of coronary heart disease. JAMA. 1998; 280: 2001–2007. 10.1001/jama.280.23.2001 CASPubMedWeb of Science®Google Scholar 63Banting W. Letter on Corpulence. Addressed to the Public. 3rd ed. London, England: Harrison; 1864. Google Scholar 64Atkins RC. Dr Atkins' New Diet Revolution. New York, NY: Harper Collins; 2002. Google Scholar 65Dena M, Bravata DM, Sanders Let al. Efficacy and safety of low-carbohydrate diets: a systematic review. JAMA. 2003; 289: 1837–1850. 10.1001/jama.289.14.1837 PubMedWeb of Science®Google Scholar 66Brehm BJ, Seeley RJ, Daniels SR, D'Alessio DA. A randomized trial comparing a very low carbohydrate diet and a calorie-restricted low fat diet on body weight and cardiovascular risk factors in healthy women. J Clin Endocrinol Metab. 2003; 88: 1617–1623. 10.1210/jc.2002-021480 CASPubMedWeb of Science®Google Scholar 67Foster GD, Wyatt HR, Hill JOet al. A randomized trial of a low-carbohydrate diet for obesity. N Engl J Med. 2003; 348: 2082–2090. 10.1056/NEJMoa022207 CASPubMedWeb of Science®Google Scholar 68Samaha FF, Iqbal N, Seshadri Pet al. A low-carbohydrate as compared with a low-fat diet in severe obesity. N Engl J Med. 2003; 348:2074- 2081. 10.1056/NEJMoa022637 Web of Science®Google Scholar 69Dansinger ML, Gleason JA, Griffith JL, Selker HP, Schaefer EJ. Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial. JAMA. 2005; 293: 43–53. 10.1001/jama.293.1.43 CASPubMedWeb of Science®Google Scholar 70Gardner CD, Kiazand A, Alhassan Set al. Comparison of the Atkins, Zone, Ornish, and LEARN diets for change in weight and related risk factors among overweight premenopausal women: the A TO Z Weight Loss Study: a randomized trial. JAMA. 2007; 297: 969–977. 10.1001/jama.297.9.969 CASPubMedWeb of Science®Google Scholar 71Heymsfield SB, Blackburn GL. Comparison of weight-loss diets. JAMA. 2007; 298: 173–174. 10.1001/jama.298.2.173-b CASPubMedWeb of Science®Google Scholar 72Shai I, Schwarzfuchs D, Henkin Y et al; for the Dietary Intervention Randomized Controlled Trial (DIRECT) Group. Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N Engl J Med. 2008; 359: 229–241. 10.1056/NEJMoa0708681 CASPubMedWeb of Science®Google Scholar 73Due A, Larsen TM, Huiling M, Hermansen K, Stender S, Astrup A. Comparison of 3 ad libitum diets for weight-loss maintenance, risk of cardiovascular disease, and diabetes: a 6-mo randomized, controlled trial. Am J Clin Nutr. 2008; 88: 1232–1241. CASPubMedWeb of Science®Google Scholar 74Polychronopoulos E, Pounis G, Bountziouka Vet al. Dietary meat fats and burden of cardiovascular disease risk factors, in the elderly: a report from the MEDIS study. Lipids Health Dis. 2010; 9: 30. 10.1186/1476-511X-9-30 CASPubMedWeb of Science®Google Scholar 75Sinha R, Cross AJ, Graubard BI, Leitzmann MF, Schatzkin A. Meat intake and mortality: a prospective study of over half a million people. Arch Intern Med. 2009; 169: 562–571. 10.1001/archinternmed.2009.6 CASPubMedWeb of Science®Google Scholar 76Popkin BM. Reducing meat consumption has multiple benefits for the world's health. Arch Intern Med. 2009; 169: 543–545. 10.1001/archinternmed.2009.2 PubMedWeb of Science®Google Scholar 77Friedman AN. High protein diets: potential effects on the kidney in renal health and disease. Am J Kidney Dis. 2004; 44: 950–962. 10.1053/j.ajkd.2004.08.020 PubMedWeb of Science®Google Scholar 78De Koning L, Fung TT, Rimm EB, Willett WC, Hu FB. Low-carbohydrate diets and risk of type 2 diabetes among men. American Diabetes Association 70th Scientific Sessions 2010; Abstract 0047-LB. http://ww2.aievolution.com/ada1001/index.cfm?do=abs.pubSearchAbstracts . Accessed July 3, 2010 Google Scholar 79van Dam RM, Willett WC, Rimm EB, Stampfer MJ, Hu FB. Dietary fat and meat intake in relation to risk of type 2 diabetes in men. Diabetes Care. 2002; 25: 417–424. 10.2337/diacare.25.3.417 PubMedWeb of Science®Google Scholar 80Ornish D. Mostly plants. Am J Cardiol.2009; 104: 957–958. 10.1016/j.amjcard.2009.05.031 PubMedWeb of Science®Google Scholar 81Halton TL, Willett WC, Liu Set al. Low-carbohydrate-diet score and the risk of coronary heart disease in women. N Engl J Med. 2006; 355: 1991–2002. 10.1056/NEJMoa055317 CASPubMedWeb of Science®Google Scholar 82Halton TL, Liu S, Manson JE, Hu FB. Low-carbohydrate-diet score and risk of type 2 diabetes in women. Am J Clin Nutr. 2008; 87: 339–346. 10.1093/ajcn/87.2.339 CASPubMedWeb of Science®Google Scholar 83Joshipura KJ, Hu FB, Manson JEet al. The effect of fruit and vegetable intake on risk for coronary heart disease. Ann Intern Med. 2001; 134: 1106–1114. 10.7326/0003-4819-134-12-200106190-00010 CASPubMedWeb of Science®Google Scholar 84Hu FB. Plant-based foods and prevention of cardiovascular disease: an overview. Am J Clin Nutr. 2003; 78(suppl): 544S–551S. 10.1093/ajcn/78.3.544S CASPubMedWeb of Science®Google Scholar 85Ferdowsian HR, Barnard ND. Effects of plant-based diets on plasma lipids. Am J Cardiol. 2009; 104: 947–956. 10.1016/j.amjcard.2009.05.032 CASPubMedWeb of Science®Google Scholar 86DeMaria AN. Eat food, not very much, mostly plants. J Am Coll Cardiol. 2010; 55: 2288–2289. 10.1016/j.jacc.2010.04.007 PubMedWeb of Science®Google Scholar 87Brinkworth GD, Noakes M, Buckley JD, Keogh JB, Clifton PM. Long-term effects of a very-low-carbohydrate weight loss diet compared with an isocaloric low-fat diet after 12 mo. Am J Clin Nutr. 2009; 90: 23–32. 10.3945/ajcn.2008.27326 CASPubMedWeb of Science®Google Scholar 88Tay J, Brinkworth GD, Noakes M, Keogh J, Clifton PM. Metabolic effects of weight loss on a very-low-carbohydrate diet compared with an isocaloric high-carbohydrate diet in abdominally obese subjects. J Am Coll Cardiol. 2008; 51: 59–67. 10.1016/j.jacc.2007.08.050 CASPubMedWeb of Science®Google Scholar 89Nordmann AJ, Nordmann A, Briel Met al. Effects of low-carbohydrate vs low-fat diets on weight loss and cardiovascular risk factors: a meta-analysis of randomized controlled trials. Arch Intern Med. 2006; 166: 285–293. 10.1001/archinte.166.3.285 CASPubMedWeb of Science®Google Scholar 90Shai I, Spence JD, Schwarzfuchs D et al; for the DIRECT Group. Dietary intervention to reverse carotid atherosclerosis. Circulation. 2010; 121: 1200–1208. 10.1161/CIRCULATIONAHA.109.879254 PubMedWeb of Science®Google Scholar 91Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol. 2003; 23: 168–175. 10.1161/01.ATV.0000051384.43104.FC CASPubMedWeb of Science®Google Scholar 92Deanfield JE, Halcox JP, Rabelink TJ. Endothelial function and dysfunction: testing and clinical relevance. Circulation. 2007; 115: 1285–1295. 10.1161/CIRCULATIONAHA.106.652859 PubMedWeb of Science®Google Scholar 93Pierce GL, Beske SD, Lawson BRet al. Weight loss alone improves conduit and resistance artery endothelial function in young and older overweight/obese adults. Hypertension. 2008; 52: 72–79. 10.1161/HYPERTENSIONAHA.108.111427 CASPubMedWeb of Science®Google Scholar 94Keogh JB, Brinkworth GD, Noakes M, Belobrajdic DP, Buckley JD, Clifton PM. Effects of weight loss from a very-low-carbohydrate diet on endothelial function and markers of cardiovascular disease risk in subjects with abdominal obesity. Am J Clin Nutr. 2008; 87: 567–576. 10.1093/ajcn/87.3.567 CASPubMedWeb of Science®Google Scholar 95Phillips SA, Jurva JW, Syed AQet al. Benefit of low-fat over low-carbohydrate diet on endothelial health in obesity. Hypertension. 2008; 51: 376–382. 10.1161/HYPERTENSIONAHA.107.101824 CASPubMedWeb of Science®Google Scholar 96Miller M, Beach V, Sorkin JDet al. Comparative effects of three popular diets on lipids, endothelial function, and C-reactive protein during weight maintenance. J Am Diet Assoc. 2009; 109: 713–717. 10.1016/j.jada.2008.12.023 PubMedWeb of Science®Google Scholar 97Spence BM, Courtney CH, McKinley MCet al. Low-fat versus low-carbohydrate weight reduction diets: effects on weight loss, insulin resistance, and cardiovascular risk: a randomized control trial. Diabetes. 2009; 58: 2741–2748. 10.2337/db09-0098 CASPubMedWeb of Science®Google Scholar 98Vlachopoulos C, Aznaouridis K, Stefanadis Cet al. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol. 2010; 55: 1318–1327. 10.1016/j.jacc.2009.10.061 PubMedWeb of Science®Google Scholar 99Dod HS, Bhardwaj R, Sajja Vet al. Effect of intensive lifestyle changes on endothelial function and on inflammatory markers of atherosclerosis. Am J Cardiol. 2010; 105: 362–367. 10.1016/j.amjcard.2009.09.038 CASPubMedWeb of Science®Google Scholar 100Vasa M, Fichtlscherer S, Aicher Aet al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res. 2001; 89: E1–E7. 10.1161/hh1301.093953 CASPubMedWeb of Science®Google Scholar 101Hill JM, Zalos G, Halcox JPJet al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Eng J Med. 2003; 348: 593–600. 10.1056/NEJMoa022287 PubMedWeb of Science®Google Scholar 102Werner N, Kosiol S, Schiegl Tet al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Eng J Med. 2005; 353: 999–1007. 10.1056/NEJMoa043814 CASPubMedWeb of Science®Google Scholar 103Padfield GJ, Newby DE, Mills NL. Understanding the role of endothelial progenitor cells in percutaneous coronary intervention. J Am Coll Cardiol. 2010; 55: 1553–1565. 10.1016/j.jacc.2009.10.070 PubMedWeb of Science®Google Scholar 104Giannotti G, Doerries C, Mocharla PSet al. Impaired endothelial repair capacity of early endothelial progenitor cells in prehypertension: relation to endothelial dysfunction. Hypertension. 2010; 55: 1389–397. 10.1161/HYPERTENSIONAHA.109.141614 CASPubMedWeb of Science®Google Scholar 105Huang PH, Chen YH, Tsai HYet al. Intake of red wine increases the number and functional capacity of circulating endothelial progenitor cells by enhancing nitric oxide bioavailability. Arterioscler Thromb Vasc Biol. 2010; 30: 869–877. 10.1161/ATVBAHA.109.200618 CASPubMedWeb of Science®Google Scholar 106Foo SY, Heller ER, Wykrzykowska Jet al. Vascular effects of a low-carbohydrate high-protein diet. PNAS. 2009; 206: 15418–15423. 10.1073/pnas.0907995106 Web of Science®Google Scholar 107Moreno PR, Sanz J, Fuster V. Promoting mechanisms of vascular health: circulating progenitor cells, angiogenesis, and reverse cholesterol transport. J Am Coll Cardiol. 2009; 53; 2315–2323. 10.1016/j.jacc.2009.02.057 CASPubMedWeb of Science®Google Scholar 108Smith SR. A look at the low-carbohydrate diet. N Engl J Med. 2009; 361: 2286–2288. 10.1056/NEJMcibr0908756 CASPubMedWeb of Science®Google Scholar 109Sacks FM, Bray GA, Carey VJet al. Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. N Eng J Med. 2009; 360: 859–873. 10.1056/NEJMoa0804748 CASPubMedWeb of Science®Google Scholar 110Executive Summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001; 285: 2486–2497. 10.1001/jama.285.19.2486 CASPubMedWeb of Science®Google Scholar 111Superko HR, King S III. Lipid management to reduce cardiovascular risk: a new strategy is required. Circulation. 2008; 117: 560–568. 10.1161/CIRCULATIONAHA.106.667428 PubMedWeb of Science®Google Scholar 112Superko HR, Gadesam RR. Is it particle size or number that correlates with risk for cardiovascular disease? Curr Atheroscler Rep. 2008; 10: 377–385. 10.1007/s11883-008-0059-2 CASPubMedWeb of Science®Google Scholar 113Cromwell WC, Otvos JD, Keyes MJet al. LDL particle number and risk of future cardiovascular disease in the Framingham Offspring Study—implications for LDL management. J Clin Lipidol. 2007; 1: 583–592. 10.1016/j.jacl.2007.10.001 PubMedWeb of Science®Google Scholar 114Kwiterovich PO Jr. Clinical relevance of the biochemical, metabolic, and genetic factors that influence low-density lipoprotein heterogeneity. Am J Cardiol. 2002; 90: 30i–47i. 10.1016/S0002-9149(02)02749-2 CASPubMedWeb of Science®Google Scholar 115Blake GJ, Otvos JD, Rifai N, Ridker PM. Low-density lipoprotein particle concentration, and size as determined by nuclear magnetic resonance spectroscopy as predictors of cardiovascular disease in women. Circulation. 2002; 106: 1930–1937. 10.1161/01.CIR.0000033222.75187.B9 CASPubMedWeb of Science®Google Scholar 116Otvos JD, Collins D, Freedman DSet al. Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial. Circulation. 2006; 113: 1556–1563. 10.1161/CIRCULATIONAHA.105.565135 CASPubMedWeb of Science®Google Scholar 117Mora S, Otvos JD, Rifai N, Rosenson RS, Buring JE, Ridker PM. Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women. Circulation. 2009; 119: 931–939. 10.1161/CIRCULATIONAHA.108.816181 CASPubMedWeb of Science®Google Scholar 118Musunuru K, Orho-Melander M, Caulfield MPet al. Ion mobility analysis of lipoprotein subfractions identifies three independent axes of cardiovascular risk. Arterioscler Thromb Vasc Biol. 2009; 29: 1975–1980. 10.1161/ATVBAHA.109.190405 CASPubMedWeb of Science®Google Scholar 119Adiels M, Olofsson S-O, Taskinen M-J, Borén J. Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome. Arterioscler Thromb Vasc Biol. 2008; 28: 1225–1236. 10.1161/ATVBAHA.107.160192 CASPubMedWeb of Science®Google Scholar 120Mora S, Otvos JD, Rosenson RS, Pradhan A, Buring JE, Ridker PM. Lipoprotein particle size and concentration by nuclear magnetic resonance and incident type 2 diabetes in women. Diabetes. 2010; 59: 1153–1160. 10.2337/db09-1114 CASPubMedWeb of Science®Google Scholar 121de Souza JA, Vindis C, Nègre-Salvayre Aet al. Small, dense HDL3 particles attenuate apoptosis in endothelial cells: pivotal role of apolipoprotein A-I. J Cell Mol Med. 2010; 14: 608–620. 10.1111/j.1582-4934.2009.00713.x CASPubMedWeb of Science®Google Scholar 122Krauss RM, Blanche PJ, Rawlings RS, Fernstrom HS, Williams PT. Separate effects of reduced carbohydrate intake and weight loss on atherogenic dyslipidemia. Am J Clin Nutr. 2006; 83: 1025–1031. 10.1093/ajcn/83.5.1025 CASPubMedWeb of Science®Google Scholar 123Karam JG, Nessim F, McFarlane SI, Feinman RD. Carbohydrate restriction and cardiovascular risk. Curr Cardiovasc Risk Rep. 2008; 2: 88–94. 10.1007/s12170-008-0018-z Google Scholar 124Volek JS, Phinney SD, Forsythe CEet al. Carbohydrate restriction has a more favorable impact on the metabolic syndrome than a low fat diet. Lipids. 2009; 44: 297–309. 10.1007/s11745-008-3274-2 CASPubMedWeb of Science®Google Scholar 125Westman EC, Feinman RD, Mavropoulos JCet al. Low-carbohydrate nutrition and metabolism. Am J Clin Nutr. 2007; 86: 276–284. 10.1093/ajcn/86.2.276 CASPubMedWeb of Science®Google Scholar 126Volek JS, Feinman RD. Carbohydrate restriction improves the features of metabolic syndrome: metabolic syndrome may be defined by the response to carbohydrate restriction. Nutr Metab (Lond). 2005; 2: 31. 10.1186/1743-7075-2-31 CASPubMedGoogle Scholar 127Forsythe CE, Philley SD, Fernandez MLet al. Comparison of low fat and low carbohydrate diets on circulating fatty acid composition and markers of inflammation. Lipids. 2008; 43: 65–77. 10.1007/s11745-007-3132-7 CASPubMedWeb of Science®Google Scholar 128Accurso A, Bernstein RK, Dahlqvist Aet al. Dietary carbohydrate restriction in type 2 diabetes mellitus and metabolic syndrome: time for a critical appraisal. Nutr Metab (Lond). 2008; 5: 9. 10.1186/1743-7075-5-9 CASPubMedWeb of Science®Google Scholar 129Feinman RD, Volek JS. Carbohydrate restriction as the default treatment for type 2 diabetes and metabolic syndrome. Scand Cardiovasc J. 2008; 42: 256–263. 10.1080/14017430802014838 CASPubMedWeb of Science®Google Scholar 130Volek JS, Forsythe CE. The case for not restricting saturated fat on a low carbohydrate diet. Nutr Metab (Lond). 2005; 2: 21. 10.1186/1743-7075-2-21 CASPubMedGoogle Scholar 131Davis NJ, Tomuta N, Schechter Cet al. Comparative study of the effects of a 1-year dietary intervention of a low-carbohydrate diet versus a low-fat diet on weight and glycemic control in type 2 diabetes. Diabetes Care. 2009; 32: 1147–1152. 10.2337/dc08-2108 CASPubMedWeb of Science®Google Scholar 132Feinglos MN, Totten SE. Are you what you eat, or how much you eat? The case of type 2 diabetes mellitus. Arch Intern Med. 2008; 168: 1485–1486. 10.1001/archinte.168.14.1485 PubMedWeb of Science®Google Scholar 133Kulkarni KR, Garber DW, Marcovina SM, Segrest JP. Quantification of cholesterol in all lipoprotein classes by VAP II method. J Lipid Res.1994; 35: 159–168. CASPubMedWeb of Science®Google Scholar 134Willett WC. The WHI joins MRFIT: a revealing look beneath the covers. Am J Clin Nutr. 2010; 91: 829–830. 10.3945/ajcn.2010.29347 CASPubMedWeb of Science®Google Scholar 135Pietiläinen KH, Korkeila M, Bogl LHet al. Inaccuracies in food and physical activity diaries of obese subjects: complementary evidence from doubly labeled water and co-twin assessments. Int J Obes. 2010; 34: 437–445. 10.1038/ijo.2009.251 CASPubMedWeb of Science®Google Scholar 136Beynen AC, Katan MB, Van Zutphen LF. Hypo- and hyperresponders: individual differences in the response of serum cholesterol concentration to changes in diet. Adv Lipid Res. 1987; 22: 115–171. 10.1016/B978-0-12-024922-0.50008-4 CASPubMedWeb of Science®Google Scholar 137Katan MB, van Gastel AC, de Rover CM, van Montfort MA, Knuiman JT. Differences in individual responsiveness of serum cholesterol to fat-modified diets in man. Eur J Clin Invest. 1988; 18: 644–647. 10.1111/j.1365-2362.1988.tb01281.x CASPubMedWeb of Science®Google Scholar 138Denke MA. Review of human studies evaluating individual dietary responsiveness in patients with hypercholesterolemia. Am J Clin Nutr. 1995; 62: 471S–477S. 10.1093/ajcn/62.2.471S CASPubMedWeb of Science®Google Scholar 139McLaughlin T, Abbasi F, Lamendola C, Reaven G. Heterogeneity in the prevalence of risk factors for cardiovascular disease and type 2 diabetes mellitus in obese individuals: effect of differences in insulin sensitivity. Arch Intern Med. 2007; 167: 642–648. 10.1001/archinte.167.7.642 CASPubMedWeb of Science®Google Scholar 140Hoyt CS, Billson FA. Low-carbohydrate diet optic neuropathy. Med J Aust. 1977; 1: 65–66. 10.5694/j.1326-5377.1977.tb130506.x PubMedWeb of Science®Google Scholar 141Foster GD, Wyatt HR, Hill JOet al. Weight and metabolic outcomes after 2 years on a low-carbohydrate versus low-fat diet: A randomized trial. Ann Intern Med. 2010; 153: 147–157. 10.7326/0003-4819-153-3-201008030-00005 PubMedWeb of Science®Google Scholar 142Vergeer M, Holleboom AG, Kastelein JJP, Kuivenhoven JA. HDL hypothesis: does high-density lipoprotein protect from atherosclerosis?. J Lipid Res. 2010; 51: 2058–2073. 10.1194/jlr.R001610 CASPubMedWeb of Science®Google Scholar 143Natarajan P, Ray KK, Cannon CP. High-Density Lipoprotein and Coronary Heart Disease. Current and Future Therapies. J Am Coll Cardiol. 2010; 55: 1283–1299. 10.1016/j.jacc.2010.01.008 CASPubMedWeb of Science®Google Scholar 144Dodani S, Grice SD, Joshi S. Is HDL function as important as HDL quantity in the coronary artery disease risk assessment?. J Clin Lipidol. 2009; 3: 70–77. 10.1016/j.jacl.2009.02.001 PubMedWeb of Science®Google Scholar 145Jenkins DJA, Wong JMW, Kendall CWCet al. The Effect of a Plant-based Low-Carbohydrate (Eco-Atkins) Diet on Body Weight and Blood Lipid Concentrations in Hyperlipidemic Subjects. Arch Intern Med. 2009; 169: 1046–1054. 10.1001/archinternmed.2009.115 CASPubMedWeb of Science®Google Scholar 146Bradley U, Spence M, Courtney CHet al. Low-fat versus low-carbohydrate weight reductions diets: Effects on weight loss, insulin resistance, and cardiovascular risk: a randomized controlled trial. Diabetes. 2009; 58: 2741–2748. 10.2337/db09-0098 CASPubMedWeb of Science®Google Scholar Citing Literature Volume25, Issue5Nutrition EducationOctober 2010Pages 528-541 ReferencesRelatedInformation
Referência(s)